We serve Chemical Name:2-Bromoisonicotinohydrazide CAS:29849-15-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Bromoisonicotinohydrazide
CAS.NO:29849-15-8
Synonyms:2-bromopyridine-4-carbohydrazide
Molecular Formula:C6H6BrN3O
Molecular Weight:216.03500
HS Code:2933399090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:68.01000
Exact Mass:214.96900
LogP:1.53880
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 2-bromopyridine-4-carbohydrazide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromopyridine-4-carbohydrazide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromopyridine-4-carbohydrazide Use and application,2-bromopyridine-4-carbohydrazide technical grade,usp/ep/jp grade.
Related News: That impacts airlines’ business, making it less financially attractive for them to fly those routes to China. 2-Bromoisonicotinohydrazide manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 2-Bromoisonicotinohydrazide supplier Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). 2-Bromoisonicotinohydrazide vendor This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 2-Bromoisonicotinohydrazide factory Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies.
